Synergistic Application of Humic Acid and Bacillus mobilis IJL Mitigates Nickel‐Induced Stress in Soybean Through Modulation of the ABA Pathway
Abstract
This study investigated the synergistic effects of plant growth–promoting rhizobacteria (PGPR) and humic acid in mitigating nickel‐induced stress in soybean. Bacterial isolates were obtained from the Pohang beach environment, among which the Bacillus mobilis IJL strain demonstrated particularly promising performance under in vitro conditions. To further evaluate the combined effects of B. mobilis IJL and humic acid, a pot experiment was established with four treatments: control (water only), IJL, humic acid (100 mg kg−1), and IJL + humic acid, under both normal and nickel‐stress conditions (50 mg kg−1). A comprehensive set of plant physiological, biochemical, antioxidant, and computational parameters was assessed. The IJL + humic acid treatment significantly improved plant growth, chlorophyll content, leaf spectral indices, antioxidant capacity, and nutrient uptake under both normal and Ni‐stressed conditions. Additionally, endogenous abscisic acid (ABA) levels were markedly reduced in IJL + humic acid–treated plants. Computational analyses indicated that metabolites produced by IJL and humic acid may inhibit two key enzymes in the ABA biosynthetic pathway, 9‐cis‐epoxycarotenoid dioxygenase (NCED3) and abscisic aldehyde oxidase (AAO3), thereby contributing to lower ABA. These findings provide novel insight into how the synergistic application of humic acid and IJL mitigates Ni‐induced stress in soybean by modulating the ABA‐mediated stress signaling pathway. The results…
Read the paper
Related studies
- Drug repositioning: a brief overview
- Cyclic nucleotide phosphodiesterases in Drosophila melanogaster
- Time-resolved in silico modeling of fine-tuned cAMP signaling in platelets: feedback loops, titrated phosphorylations and pharmacological modulation
- Current View on Green Tea Catechins Formulations, Their Interactions with Selected Drugs, and Prospective Applications for Various Health Conditions
- In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer’s Disease
- Development and In Vitro Evaluation of Controlled Release Viagra® Containing Poloxamer-188 Using Gastroplus™ PBPK Modeling Software for In Vivo Predictions and Pharmacokinetic Assessments
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.